Hey guy's and gal's pulled this off the other site,

New Post Public Reply Private Reply Replies (1) Message Board
Jaxdawson
Hey guy's and gal's pulled this off the other site, compliments of givemeshelter.
Let me know if you think it's legit?

gimmeshelter Tuesday, 04/22/14 11:29:17 PM
Re: None
Post # of 163171
Response from Lakeshore on zoning and permits:

I wrote Mr. Steve Salmons, director of community and development services in hopes of clearing up these issues of debate on the msg. board. Here are the emails we shared, which clears up very little in my view:



Steve Salmons (ssalmons@lakeshore.ca)



ssalmons@lakeshore.ca
Steve Salmons
Director of Community & Development Services



Town of Lakeshore
T 519-728-5004 x292
ssalmons@lakeshore.ca




To: Steve Salmons

mailto:ssalmons@lakeshore.ca

Hello Mr. Salmons,

I am writing to you in hopes you can clear up a few issues regarding CEN Biotech and their current project to build a medical marihuana facility located at North Rear and Manning Roads in Lakeshore.

I am an investor in CEN Biotech and have been trying to follow the process, but as you likely know, there are many conflicting reports regarding zoning issues and building permits needed to comply with municipal and provincial requirements to proceed with their application to Health Canada for licensing.

I'm guessing you've probably received more than a few inquiries into this matter and if you don't have time to answer my questions, I understand. If you can reply, let me say thanks in advance for taking the time.

To begin with, I read the most recent council meeting minutes from the April 8 session where you stated that you had advised the proponent (CEO Bill Chaaban, I assume) that "rezoning and a site plan approval will be required to operate a facility beyond what is allowed in the current agricultural (with value added) zoning that currently exists."

I understand the project's production and need for employees will exceed the limits imposed by the current zoning. I read through the HC guidelines and the MMPR regulations and could not find any requirement that the production sites be zoned as industrial, yet in a recent written statement issued by Adam Szymczak, senior planner for the planning and economic development committee of neighboring city Windsor, also of Essex County, states that, "medical marihuana facilities must be zoned industrial to comply."

Does this stipulation also apply to Lakeshore or is that just a requirement of Windsor and not the county, Health Canada or the MMPR by-laws?

What does CEN Biotech need to do to be in compliance with Lakeshore city codes and zoning laws before they can begin production? (Assuming the licence from HC is forthcoming.)

Will the property need to be rezoned or can amendments be made to accommodate their production facility?

Has the proponent begun addressing this issue with your agency and/or the city council to effect the necessary change?

Assuming CEN Biotech is working diligently to comply, what kind of time frame are we looking at until an agreement can be reached so they can proceed with licensing and production?

Conjecture abounds that this process is either,
a). a simple process that can be remedied in quick fashion, or
b). a complicated process that will not be quickly remedied, or
c). a deal-breaker because of residential zoning with dwellings too close to the proposed production facility to allow for any kind of zoning approval.

What is your view on what it will take for the proponent to become compliant and ready to proceed to the next step?

I've reviewed the city's online guide for "Buildings and Permits" which states that permits are required for the following building projects, which I'm assuming apply to the construction of this site:

* new and replacement water lines
* construction of a new building
* any additions to an existing building
* structural alterations
* renovate, repair or add to a building
* change a building's use
* install or change load-bearing walls
* make new openings or change the size of doors and windows
* excavate a basement or construct a foundation
* install plumbing
* accessory structure larger than 108 square feet
* a deck more than 24' above ground
* new basement entrance

Are the proper permits for these projects in place?

If not, is the proponent working to comply or will they be addressed at the April 22 council meeting?

Is the proponent in danger of facing a work stoppage due to a lack of building permits acquired or any other issues such as permits for installation of gas, plumbing or electrical installation?

And finally, are there any other requirements that the proponent has not met that need to be complied with before gaining approval from the city to proceed and be ready for production?

I will be eagerly awaiting the release of minutes from Tuesday's council meeting to learn more on the progress of the project.

And thanks again for your time in reading and answering my letter.

Michael S.




© Steve Salmons (ssalmons@lakeshore.ca)

Add to contacts

4:00 PM





To: 'Michael S.'







ssalmons@lakeshore.ca

Michael,

I will briefly answer some of your questions, as many of your questions are speculative in nature, or without context.



Licensing is between Health Canada and the proponent, the Town has no involvement. The federal program does require any proponent to comply with all federal, provincial and municipal requirements. Zoning would be a typical requirement.



The Town does view the production of marihuana as an agricultural crop. It is the extent of processing that will determine if any further zoning is required by a proponent. Zoning requests are routine, and relatively straight forward, subject to the approval of Council.



We have been notified by CEN Biotech (as is required in the Act) of their intent to produce medical marihuana at a specific site in Lakeshore. CEN Biotech has not advised Lakeshore that they are seeking or require any zoning accommodations at this time.



You should contact the company for further information.

JAX

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Southwire Unveils 2025 Sustainability Report: Changes Ahead

Updated Category News Views 9

Southwire's Bold Sustainability Vision for the Future Southwire's latest foray into sustainability leaves me chewing over a whole new set of ambitious targets. As the veteran player in North America's wire and cable scene, they're not just running the presses—they're mapping the future with grand gestures. July 30, 2026, marks their announcement of the 2025...

Continue Reading
Wells Fargo to Share Insights on Q4 2024 Earnings Call Soon

Updated Category News Views 267

Wells Fargo Announces Upcoming Earnings Report Wells Fargo & Company (NYSE: WFC) is set to reveal its fourth quarter earnings for 2024 on January 15. This anticipated announcement is scheduled to be shared around 7:00 a.m. Eastern time, allowing investors and financial enthusiasts to gain crucial insights into the company's financial performance and strategic direction....

Continue Reading
Peter Schiff Challenges Tariff Ruling as Inflation Cools

Updated Category News Views 300

Breaking Down Schiff’s Take on Trade Look, this whole talk about foreign countries ripping off America? It’s a bunch of hot air, if you ask me. Peter Schiff, that famous economist who’s always got something to say, slammed that narrative recently. Ya know, he's making waves on X, saying, "No country has been ripping off America." I mean, he's basically flipping the...

Continue Reading
LifeMD's Financial Growth Highlights and Strategic Outlook

Updated Category News Views 200

LifeMD Reports Impressive Financial Growth LifeMD, Inc. (NASDAQ: LFMD), a prominent virtual healthcare provider, has showcased remarkable resilience in its third-quarter financial results for the year. The company's total revenue has surged by 13% year-over-year, reaching $60.2 million, with adjusted EBITDA rising significantly by 20%, totaling $5.1 million. These results...

Continue Reading
Intellia Therapeutics Investors Explore Legal Options for Rights

Updated Category News Views 188

Understanding the Class Action for Intellia Therapeutics As an investor in Intellia Therapeutics, Inc. (NASDAQ: NTLA), staying informed is vital, especially regarding your legal rights. Recently, the Rosen Law Firm, a notable player in the investor rights landscape, has issued reminders about a critical upcoming deadline concerning a class action lawsuit aimed at the...

Continue Reading